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E-mail: gilbert.greub@chuv.chMalaria is a severe disease associated with signiﬁcant mortality,
mainly attributed to Plasmodium falciparum and to delayed
treatment [1]. Patients with clinical criteria of severe disease
should be hospitalized and aggressively treated with intravenous
anti-parasite drugs. UK recommendations suggest treating
intravenously as soon as the parasitaemia is above 2% [2].
The correlation between parasitaemia and severity of disease
is well established for quantiﬁcation derived from microscopy
[3]. Correlation between clinical severity and DNAw Microbe and New Infect 2015; 5: 10–12
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for other infections, such as Streptococcus pneumoniae [4],
Staphylococcus aureus [5] or Neisseria meningitidis [6], but the
value of real-time PCR quantiﬁcation to predict outcome is
unknown for P. falciparum infection.
In our diagnostic laboratory, real-time Taqman PCR has been
used to conﬁrm species identiﬁcation for every positive mi-
croscopy, as a systematic internal quality control since January
2004. This quantitative PCR targeting the 18S rRNA encoding
gene [7], has also been implemented in other diagnostic
microbiology laboratories [8,9]. The objective of this work was
to assess (among patients with single P. falciparum infection)
whether parasitaemia determined by microscopy and/or PCR
correlated with the clinical severity of malaria.
From 1 January 2004 to 31 December 2011, we included in
our work all patients found infected by only P. falciparum, as
determined by Giemsa-stained thin smear and by a multiplex
PCR performed on their ﬁrst EDTA–blood sample. The
included patients were adults (>16 years old) hospitalized at the
University Hospital, Lausanne (Switzerland) or consulting at the
Department of Ambulatory Care and Community Medicine of
Lausanne’s University Hospital. This project was approved by
our local ethics committee.
For microscopy, parasitaemia was initially reported in %. The
number of P. falciparum parasites per mL of blood was esti-
mated assuming that 1 μL contains 5 × 106 red blood cells.
Hence, 1% parasitaemia corresponded to 50 000 parasites/μL
of blood and to 50 000 000 parasites/mL. Quantiﬁcation was
then converted in log parasites/mL.
All samples positive for P. falciparum by direct microscopy
were conﬁrmed by a multiplex Plasmodium quantitative real-
time PCR [7], detecting the four most common human Plas-
modium species (P. falciparum, Plasmodium ovale, Plasmodium
vivax and Plasmodium malariae). Then, using the set of primers
and probes speciﬁc for P. falciparum, we conﬁrmed all positive
results by a subsequent P. falciparum monoplex PCR to pre-
cisely quantify the number of parasite copies/mL of blood.
Quantiﬁcation was ﬁrst expressed in number of DNA copies/
mL and then converted in log copies/mL as described in Dor-
mond et al. [10].
Demographic (country of exposure) and clinical character-
istics were retrospectively retrieved from clinical charts. Eight
characteristics, following the WHO criteria of severe malaria
[1], were considered: (i) cerebral malaria (coma) or impairment
of consciousness, (ii) adult respiratory distress syndrome or
pulmonary oedema, (iii) haemostatic abnormalities (bleeding or
disseminated intravascular coagulation), (iv) severe hypotension
(<70 mmHg of systolic blood pressure) or shock, (v) severe
anaemia (haemoglobin <50 g/L), (vi) acute renal failureEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 1. Criteria of severe malaria among 112 patients
presenting single Plasmodium falciparum infection (20
patients presented at least one criteria of severe malaria)
Criteria of severe malaria Frequencies
Cerebral malaria (coma) or impairment
of consciousness
12/112 (11%)
Jaundice (total serum bilirubin 50 μmol/L) 8/112 (7%)
Haemostatic abnormalities (bleeding or DIC) 4/112 (4%)
Severe hypotension (<70 mmHg of systolic
blood pressure)
4/112 (4%)
Acute renal failure (creatinine concentration
>265 μmol/L)
2/112 (2%)
ARDS or pulmonary oedema 2/112 (2%)
Severe anaemia (haemoglobin <50 g/L) 0/112 (0%)
Severe hypoglycaemia (<2.2 mmol/L)a 0/112 (0%)
ARDS, adult respiratory distress syndrome; DIC, disseminated intravascular
coagulation.
aInformation mainly available in severe cases.
NMNI Dormond et al. PCR for malaria severity 11(creatinine concentration >265 μmol/L), (vii) jaundice (total
serum bilirubin 50 μmol/L) and severe hypoglycaemia
(<2.2 mmol/L). Patients with one or more than one of these
criteria were considered as severe malaria cases. The statistical
analyses have been performed using the GRAPHPAD PRISM soft-
ware 5.02 (GraphPad Software, La Jolla, CA, USA). Medians
were compared using the Wilcoxon test.
The correlation between clinical severity and parasitaemia as
well as PCR quantiﬁcation was assessed for 112 patients with
isolated P. falciparum infections conﬁrmed by PCR. Most of
those patients exhibited no criteria of severity (92/112; 82.1%)
or one single criterion (11/112; 9.8%). Seven patients presentedFIG. 1. Correlation between ﬁrst parasite
load and severity criteria according to mi-
croscopy (a) and PCR (b). The size of each
circle represents the number of subjects
with a given Plasmodium level.
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This is an open access artitwo criteria, one patient presented three criteria and one pa-
tient presented four criteria of severity. Neurological impair-
ment and jaundice were the commonest observed criteria of
severe malaria (Table 1). Notably, except for one patient who
had returned from South America, all patients acquired
P. falciparum infection in sub-Saharan Africa (60.0% in West
Africa, 36.4% in Central Africa and 2.7% in East Africa).
As expected, parasitaemia estimated by microscopy signiﬁ-
cantly correlated with clinical severity (Fig. 1a). Parasitaemia was
signiﬁcantly higher among patients with at least one criterion of
severe malaria (median of 7.63 log copies/mL; interquartile range
(IQR) 7.00–8.39 log copies/mL) compared with patients with
0 severity criteria (median of 7.09 log copies/mL; IQR 5.70–7.74
log copies/mL; p < 0.001). Moreover, both of the patients with at
least three severity criteria exhibited a parasitaemia >100 × 106
parasites/mL (>2%; log 8 parasites/mL).
A similar correlation between clinical severity and parasite
load determined by PCR could be demonstrated (Fig. 1b). The
number of Plasmodium-speciﬁc DNA copies/mL was signiﬁ-
cantly higher among patients with one or more severity criteria
(median of 6.87 log copies/mL; IQR 5.87–7.73 log copies/mL)
compared with patients with 0 severity criteria (median of 6.22
log copies/mL; IQR 5.17–6.94 log copies/mL; p < 0.001). The
number of plasmodial DNA copies was high, i.e. above
16 900 000 copies/mL (log 7 copies/mL), among both patients
with at least three criteria of severe malaria. These two patients
with at least three criteria of severe malaria both exhibited alf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 5, 10–12
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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patients with parasitaemia of 2% had an odds ratio of severe
P. falciparum malaria that was 12-fold higher than in patients
with <2% parasitaemia [11], and this threshold was proposed to
decide on the choice of parenteral anti-malarials to administer
[2]. According to our results, when PCR is used for quantiﬁ-
cation, a threshold of parasitaemia of >log 7 might be proposed
for such a decision. Moreover, an added value of PCR quanti-
ﬁcation is also present for low DNA load, as all six patients with
a parasitaemia of <log 4 exhibited no criteria of severity.
However, interpretation of quantitative PCR results should
take into account the overall clinical presentation, as low par-
asitaemia has been reported in patients with severe malaria, due
to splenic sequestration [12], especially in non-immune pa-
tients. This <log 4 cut-off should be challenged in future larger
studies, because our work relies on a small number of patients
and we observed a large dynamic range of parasitaemia among
patients without criteria of severity. Practically, the quantitative
PCR will not replace microscopy, which provides an earlier
result and is available 24/24 and 7/7. The main advantage of
having such an additional quantitative approach is for clinical
studies [10] and for speciﬁc cases, such as estimating the par-
asitaemia retrospectively in a dead patient when full blood is no
longer available [13].
In conclusion, we observed a signiﬁcant correlation be-
tween ﬁrst parasite load as determined by microscopy and the
number of severity criteria. We also observed a signiﬁcantly
higher parasite load as determined by PCR in patients with at
least one criterion of severe malaria compared with those
without any criteria of severity. Hence, quantitative PCR might
be useful to predict the outcome of patients with P. falciparum
infection and to guide prescription of intravenous anti-malarial
treatment.Conﬂicts of interestNone declared.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
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